» Authors » Raffaele Pellerito

Raffaele Pellerito

Explore the profile of Raffaele Pellerito including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1027
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Campochiaro C, Hoffmann-Vold A, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, et al.
Rheumatology (Oxford) . 2022 Nov; 62(7):2483-2491. PMID: 36413079
Objective: Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc) patients. We aimed to investigate the impact of sex on SSc-ILD. Methods: EUSTAR...
2.
Rossi D, Sciascia S, Cecchi I, Saracco M, Montabone E, Modena V, et al.
J Clin Med . 2021 Jan; 10(2). PMID: 33466837
Background: B-cells have been suggested to play a role in the pathogenesis of systemic sclerosis (SSc), representing, therefore, a potential therapeutic target. Objectives: We aimed at investigating the 36-month outcomes...
3.
Bodio C, Grossi C, Pregnolato F, Favalli E, Biggioggero M, Marchesoni A, et al.
Autoimmun Rev . 2020 Mar; 19(5):102509. PMID: 32173513
Up to 40% of patients treated with tumor necrosis factor alpha inhibitors (TNFi) do not respond to therapy. Testing drug bioavailability and/or anti-drug antibody (ADAb) levels may justify dosage adjustment...
4.
Marchesoni A, DAngelo S, Anzidei M, Bortolotti R, Cantini F, Caramella D, et al.
Clin Exp Rheumatol . 2018 Dec; 37(4):575-584. PMID: 30557127
Objectives: The aim of this study was to develop a Delphi consensus statement between rheumatologists and radiologists for the diagnosis and monitoring of axial spondyloarthritis (axial-SpA). Methods: Following an extensive...
5.
Salaffi F, Di Carlo M, Iannone F, Fedele A, Epis O, Pellerito R, et al.
Semin Arthritis Rheum . 2017 Nov; 47(5):619-629. PMID: 29102157
Objective: To assess validity, responsiveness and interpretability of the UltraSound-CLinical ARthritis Activity (US-CLARA) index in patients with rheumatoid arthritis (RA). Methods: In this longitudinal study were involved RA patients starting...
6.
Favalli E, Sinigaglia L, Becciolini A, Grosso V, Gorla R, Bazzani C, et al.
Int J Rheum Dis . 2017 Oct; 21(2):422-430. PMID: 29082659
Objectives: To evaluate the 2-year retention rate of golimumab compared with etanercept and adalimumab as second-line biologic agent in rheumatoid arthritis (RA) patients who failed a previous tumor necrosis factor...
7.
Manara M, Caporali R, Favalli E, Grosso V, Atzeni F, Sarzi Puttini P, et al.
Clin Exp Rheumatol . 2017 Aug; 35(5):804-809. PMID: 28770712
Objectives: We aimed to provide data on golimumab real-life use in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) from a multicentre observational registry of Northern Italy. Methods:...
8.
Gonzalez-Gay M, Montecucco C, Selva-OCallaghan A, Trallero-Araguas E, Molberg O, Andersson H, et al.
Clin Exp Rheumatol . 2017 Aug; 36(1):44-49. PMID: 28770709
Objectives: To evaluate if the timing of appearance with respect to disease onset may influence the arthritis presentation pattern in antisynthetase syndrome (ASSD). Methods: The patients were selected from a...
9.
Buondonno I, Rovera G, Sassi F, Rigoni M, Lomater C, Parisi S, et al.
PLoS One . 2017 Jun; 12(6):e0178463. PMID: 28582403
The aim of this study was to evaluate differences in T helper cell sub-types and osteoclast (OCs) precursors in peripheral blood between patients affected by early rheumatoid arthritis (eRA) and...
10.
Codullo V, Iannone F, Sinigaglia L, Favalli E, Sarzi-Puttini P, Atzeni F, et al.
Clin Exp Rheumatol . 2017 May; 35(4):660-665. PMID: 28516879
Objectives: Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly improved outcomes in rheumatoid arthritis (RA). They are widely used in clinical practice and drug registries give us...